Diagnostic Accuracy of Lung Ultrasound for Pneumonia Diagnosis in Children

NCT07331311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2026-01-09

No results posted yet for this study

Summary

Chest X-ray is historically being used as an imaging standard to aid to the diagnosis of childhood pneumonia, however, the evidence does not support it as a perfect imaging tool. As an alternative to CXR, lung ultrasound (LUS) could be used as the imaging of choice in children and studies have demonstrated its good accuracy to diagnose childhood pneumonia. However, most diagnostic studies have used CXR as a reference standard.

In absence of a 'gold standard' approach, there is a risk that large proportion of children with pneumonia and severe pneumonia could be 'missed' if clinicians relied on LUS only.

This research aims to evaluate the diagnostic benefit of LUS in children compared against 'gold standard' diagnosis which is derived based on the clinical information, imaging and laboratory investigations.

Conditions

Interventions

DIAGNOSTIC_TEST

LUS as a chest imaging tool

Each study participant receives LUS scan followed by CXR as chest imaging modality. LUS is the diagnostic test under investigation, compared against clinical gold standard (described later).

Sponsors & Collaborators

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • Global Health Research and Medical Interventions Institute (GlohMed), Nepal

    collaborator UNKNOWN
  • Nagasaki University

    lead OTHER

Principal Investigators

  • Suraj Bhattarai, MBBS, MSc, DTM&H · London School of Hygiene and Tropical Medicine/ Nagasaki University School of Tropical Medicine and Global Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-19
Primary Completion
2025-05-15
Completion
2025-06-30

Countries

  • Nepal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331311 on ClinicalTrials.gov